1. Home
  2. MED vs TVGN Comparison

MED vs TVGN Comparison

Compare MED & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MEDIFAST INC

MED

MEDIFAST INC

N/A

Current Price

$9.51

Market Cap

120.6M

ML Signal

N/A

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$6.55

Market Cap

63.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MED
TVGN
Founded
1980
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Blank Checks
Sector
Consumer Staples
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
120.6M
63.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
MED
TVGN
Price
$9.51
$6.55
Analyst Decision
Hold
Hold
Analyst Count
1
1
Target Price
$12.00
N/A
AVG Volume (30 Days)
245.3K
547.1K
Earning Date
05-20-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$934,842,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.04
$0.14
52 Week High
$15.37
$10.76

Technical Indicators

Market Signals
Indicator
MED
TVGN
Relative Strength Index (RSI) 27.04 79.36
Support Level N/A $0.53
Resistance Level $12.21 N/A
Average True Range (ATR) 0.39 0.56
MACD -0.05 0.79
Stochastic Oscillator 5.12 59.17

Price Performance

Historical Comparison
MED
TVGN

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: